Molecular Mechanism of Dihydroquercetin in Ameliorating Metabolic Dysfunction–Associated Steatotic Liver Disease: Insights Into the HIF ‐1α/ VEGF Pathway

Documenti analoghi

• Effects and Mechanisms of Stevioside on Metabolic Dysfunction‐Associated Steatotic Liver Disease
  di: Kangjun Li, et al.
  Pubblicazione: (2026)
• Aspirin Use Does Not Significantly Reduce the Risk of Liver Fibrosis in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease
  di: Linlin Yin, et al.
  Pubblicazione: (2025)
• The Burden of Nonmalignant Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Western Pacific Region: A Systematic Analysis From 1990 to 2021
  di: Qichao Ge, et al.
  Pubblicazione: (2025)
• Effects of Quercetin on Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis
  di: Dachuan Jin, et al.
  Pubblicazione: (2025)
• Postbiotics as Antiinflammatory and Immune‐Modulating Bioactive Compounds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
  di: Yusuf Yilmaz
  Pubblicazione: (2024)